Ken‐Ichi Yamamura

581 total citations
16 papers, 483 citations indexed

About

Ken‐Ichi Yamamura is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Ken‐Ichi Yamamura has authored 16 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Oncology. Recurrent topics in Ken‐Ichi Yamamura's work include Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and CRISPR and Genetic Engineering (2 papers). Ken‐Ichi Yamamura is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and CRISPR and Genetic Engineering (2 papers). Ken‐Ichi Yamamura collaborates with scholars based in Japan, United States and Germany. Ken‐Ichi Yamamura's co-authors include Kimi Araki, Tadashi Kaname, Takao Senda, Shigeki Yuasa, Osamu Taguchi, Qiwen Fan, Kimiyoshi Arimura, Tadahiko Igakura, Yoshiro Toyama and Takashi Muramatsu and has published in prestigious journals such as Developmental Biology, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease and Developmental Dynamics.

In The Last Decade

Ken‐Ichi Yamamura

16 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken‐Ichi Yamamura Japan 9 313 146 70 56 56 16 483
Shigeto Takeuchi Japan 11 427 1.4× 91 0.6× 50 0.7× 79 1.4× 86 1.5× 22 732
Sébastien Flajollet France 12 333 1.1× 231 1.6× 58 0.8× 25 0.4× 80 1.4× 17 616
Suzanne D. Westfall United States 11 406 1.3× 69 0.5× 61 0.9× 58 1.0× 82 1.5× 12 607
Maria Teresa Quaranta Italy 16 482 1.5× 175 1.2× 65 0.9× 20 0.4× 73 1.3× 26 790
Cam T. Ha United States 15 247 0.8× 208 1.4× 38 0.5× 25 0.4× 37 0.7× 16 644
Georgia Zoumpoulidou United Kingdom 11 290 0.9× 158 1.1× 40 0.6× 29 0.5× 86 1.5× 15 504
Donald E. Fleenor United States 14 248 0.8× 76 0.5× 77 1.1× 93 1.7× 49 0.9× 20 503
Eyal Fima Israel 13 248 0.8× 336 2.3× 72 1.0× 32 0.6× 139 2.5× 23 645
Ajoy Kumar Samraj Germany 11 263 0.8× 75 0.5× 27 0.4× 35 0.6× 51 0.9× 12 408
Jon Lecanda Spain 12 294 0.9× 84 0.6× 55 0.8× 55 1.0× 226 4.0× 16 528

Countries citing papers authored by Ken‐Ichi Yamamura

Since Specialization
Citations

This map shows the geographic impact of Ken‐Ichi Yamamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken‐Ichi Yamamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken‐Ichi Yamamura more than expected).

Fields of papers citing papers by Ken‐Ichi Yamamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken‐Ichi Yamamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken‐Ichi Yamamura. The network helps show where Ken‐Ichi Yamamura may publish in the future.

Co-authorship network of co-authors of Ken‐Ichi Yamamura

This figure shows the co-authorship network connecting the top 25 collaborators of Ken‐Ichi Yamamura. A scholar is included among the top collaborators of Ken‐Ichi Yamamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken‐Ichi Yamamura. Ken‐Ichi Yamamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Abe, Koichiro, Kimi Araki, Masahiro Sato, et al.. (2012). A Cre knock‐in mouse line on the Sickle tail locus induces recombination in the notochord and intervertebral disks. genesis. 50(10). 758–765. 6 indexed citations
2.
Yamashita, Ryo, et al.. (2009). Defective development of the gall bladder and cystic duct in Lgr4‐ hypomorphic mice. Developmental Dynamics. 238(4). 993–1000. 55 indexed citations
3.
Reifenberg, Kurt, Eberhard Hildt, Bernd Lecher, et al.. (2006). IFNγ expression inhibits LHBs storage disease and ground glass hepatocyte appearance, but exacerbates inflammation and apoptosis in HBV surface protein‐accumulating transgenic livers. Liver International. 26(8). 986–993. 10 indexed citations
4.
Gillmore, Julian D., Winston L. Hutchinson, Jeff Herbert, et al.. (2004). Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination?. Immunology. 112(2). 255–264. 49 indexed citations
5.
Honda, Masahiro, Tadashi Kaname, Ruriko Igata‐Yi, et al.. (1999). Novel intronic polymorphisms in the presenilin‐2 gene and a case‐control association study of Alzheimer’s disease. Psychiatry and Clinical Neurosciences. 53(5). 579–585. 3 indexed citations
7.
Igakura, Tadahiko, Tadashi Kaname, Hisako Muramatsu, et al.. (1998). A Null Mutation in Basigin, an Immunoglobulin Superfamily Member, Indicates Its Important Roles in Peri-implantation Development and Spermatogenesis. Developmental Biology. 194(2). 152–165. 245 indexed citations
8.
Saheki, Takeyori, Kouji Mori, Keiko Kobayashi, et al.. (1995). Importance of ornithine transcarbamylase (OTC) deficiency in small intestine for urinary orotic acid excretion: Analysis of OTC-deficient spf-ash mice with OTC transgene. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1270(1). 87–93. 6 indexed citations
9.
Yamamura, Ken‐Ichi, Fumi Tashiro, Shigehiro Yi, et al.. (1993). Transgenic mouse model for human genetic diseases. Molecular Reproduction and Development. 36(2). 248–250. 1 indexed citations
10.
Yamamura, Ken‐Ichi, Toru Miyazaki, Masashi Uno, Tomomi Toyonaga, & Jun‐ichi Miyazaki. (1992). Non-obese diabetic transgenic mouse. Springer Seminars in Immunopathology. 14(2). 115–25. 4 indexed citations
11.
Araki, Kimi, et al.. (1992). Developmental and Liver-Specific Expression Directed by the Serum Amyloid P Component Promoter in Transgenic Mice1. The Journal of Biochemistry. 111(6). 736–738. 25 indexed citations
12.
Takiguchi, Masaki, et al.. (1989). Tissue‐ and developmental stage‐specific expression of the rat ornithine carbamoyltransferase gene in transgenic mice. Developmental Genetics. 10(5). 393–401. 15 indexed citations
13.
Wakasugi, Shoji, Takeaki Inomoto, Masahiro Uehira, et al.. (1989). Liver‐specific and high‐level expression of human serum amyloid P component gene in transgenic mice. Developmental Genetics. 10(5). 365–371. 13 indexed citations
14.
Wakasugi, Shoji, Takeaki Inomoto, Shuichiro Maeda, et al.. (1988). An autosomal dominant mutation of facial development in a transgenic mouse. Developmental Genetics. 9(3). 203–212. 7 indexed citations
15.
Yamamura, Ken‐Ichi, Shuichiro Maeda, Takeaki Inomoto, et al.. (1987). Tissue‐specific and developmental expression of human transthyretin gene in transgenic mice. Developmental Genetics. 8(4). 195–205. 29 indexed citations
16.
Yamamura, Ken‐Ichi, Zen-ichi Ogita, & Clement L. Markert. (1979). Epigenetic formation of lactate dehydrogenase isozymes in the house mouse, Mus musculus. Journal of Experimental Zoology. 208(3). 271–279. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026